Wearable Devices LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 167,513 ordinary shares, representing 4.99% of Wearable Devices Ltd.
NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly reported beneficial ownership of 8.00% of Wearable Devices Ltd.'s ordinary shares, totaling 230,752 shares.
NASDAQ
Armistice Capital and Steven Boyd have reduced their beneficial ownership in Wearable Devices Ltd. to 4.99%, falling below the 5% reporting threshold.
NASDAQ
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, revealing a 9.99% beneficial ownership stake in Wearable Devices Ltd.'s Ordinary Shares as of March 31, 2025.
NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly disclosed a beneficial ownership of 9.99% of Wearable Devices Ltd.'s Ordinary Shares, held in the ordinary course of business.
NASDAQ
Guy Wagner has filed an amended Schedule 13G, disclosing a 2.9% beneficial ownership stake in Wearable Devices Ltd. as of December 31, 2024.
NASDAQ
Asher Dahan has filed an amended Schedule 13G, disclosing a 2.2% beneficial ownership stake in Wearable Devices Ltd., including options and restricted share units, following a reverse stock split in October 2024.
NASDAQ
An amended Schedule 13G filing reveals Leeor Langer's beneficial ownership of 2.2% of Wearable Devices Ltd.'s Ordinary Shares as of December 31, 2024, including exercisable options and vesting restricted share units.